Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
BioLine RX (BLRX US)
Watchlist
4
Analysis
Health Care
•
Israel
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
BioLine RX
•
23 Aug 2024 00:00
•
Issuer-paid
BLRX: On Track for 60% Formulary Placement
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
203 Views
Share
bullish
•
BioLine RX
•
20 Aug 2024 22:00
•
Issuer-paid
BLRX: On Track for 60% Formulary Placement
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
142 Views
Share
bullish
•
BioLine RX
•
10 Jun 2024 22:00
•
Issuer-paid
BLRX: First Quarter 2024 Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
202 Views
Share
bullish
•
BioLine RX
•
04 May 2017 18:00
•
Issuer-paid
Multiple shots on goal and multiple partners
BioLineRx is currently focused on the development of BL-8040, which is a short peptide antagonist for CXCR4, a chemokine receptor involved with...
Edison Investment Research
Follow
142 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x